RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation

Oncogene

Volumn 30, Issue 12, 2011, Pages 1460-1469

  Durie, D ^a,b   Lewis, S M ^a,d   Liwak, U ^a,b   Kisilewicz, M ^a,b   Gorospe, M ^c   Holcik, M ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d ATLANTIC CANCER RESEARCH INSTITUTE   (Canada)

Author keywords

cancer; HuR; internal initiation; ITAF; translation; XIAP

Indexed keywords

ETOPOSIDE; HUR PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN MCL 1; X LINKED INHIBITOR OF APOPTOSIS;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; OPERON; POLYSOME; PRIORITY JOURNAL; PROTEIN BINDING; TRANSLATION INITIATION;

AMINO ACID SEQUENCE; ANTIGENS, SURFACE; CELL SURVIVAL; CYTOPROTECTION; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA-BINDING PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79953067364     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.527     Document Type: Article

References (50)

1. Abdelmohsen K, Lal A, Kim HH, Gorospe M. (2007). Posttranscrip-tional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6: 1288-1292. (Pubitemid 47327958)
2. Baird SD, Lewis SM, Turcotte M, Holcik M. (2007). A search for structurally similar cellular internal ribosome entry sites. Nucleic Acids Res 35: 4664-4677. (Pubitemid 47250339)
3. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H et al. (2007). A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell 28: 501-512. (Pubitemid 350030573)
4. Coleman J, Miskimins WK. (2009). Structure and activity of the internal ribosome entry site within the human p27 Kip1 5'-untranslated region. RNA Biol 6: 84-89.
5. Dean E, Jodrell D, Connolly K, Danson S, Jolivet J, Durkin J et al. (2009). Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer. J Clin Oncol 27: 1660-1666.
6. Dean EJ, Ranson M, Blackhall F, Dive C. (2007). X-linked inhibitor of apoptosis protein as a therapeutic target. Expert Opin Ther Targets 11: 1459-1471. (Pubitemid 350200481)
7. Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M et al. (2006). Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 23: 23.
8. Denkert C, Weichert W, Pest S, Koch I, Licht D, Kobel M et al. (2004a). Overexpression of the embryonic-lethal abnormal visionlike protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64: 189-195. (Pubitemid 38114097)
9. Denkert C, Weichert W, Winzer KJ, Muller BM, Noske A, Niesporek S et al. (2004b). Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 10: 5580-5586. (Pubitemid 39100499)
10. Dormoy-Raclet V, Menard I, Clair E, Kurban G, Mazroui R, Di Marco S et al. (2007). The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the beta-actin mRNA in a U-rich-element-dependent manner. Mol Cell Biol 27: 5365-5380. (Pubitemid 47124391)
11. Dubrez-Daloz L, Dupoux A, Cartier J. (2008). IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 7: 1036-1046.
12. Erkinheimo TL, Sivula A, Lassus H, Heinonen M, Furneaux H, Haglund C et al. (2005). Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma. Gynecol Oncol 26: 26.
13. Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, Wilson GM. (2007). Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J Biol Chem 282: 20948-20959. (Pubitemid 47099908)
14. Galban S, Kuwano Y, Pullmann Jr R, Martindale JL, Kim HH, Lal A et al. (2008). RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol 28: 93-107.
15. Graber TE, Baird SD, Kao PN, Mathews MB, Holcik M. (2010). NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death Differ 17: 719-729.
16. Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M. (2009). Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 15: 363-375.
17. Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H et al. (2005). Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65: 2157-2161. (Pubitemid 40490122)
18. Heinonen M, Fagerholm R, Aaltonen K, Kilpivaara O, Aittomaki K, Blomqvist C et al. (2007). Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res 13: 6959-6963. (Pubitemid 350276875)
19. Hinman MN, Lou H. (2008). Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65: 3168-3181.
20. Holcik M. (2003). Translational upregulation of the X-linked inhibitor of apoptosis. Ann N Y Acad Sci 1010: 249-258. (Pubitemid 38264984)
21. Holcik M, Gordon BW, Korneluk RG. (2003). The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol. Cell. Biol 23: 280-288. (Pubitemid 36008520)
22. Holcik M, Graber T, Lewis SM, Lefebvre CA, Lacasse E, Baird S. (2005). Spurious splicing within the XIAP 5' UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system. RNA 11: 1605-1609. (Pubitemid 41505533)
23. Holcik M, Korneluk RG. (2000). Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol 20: 4648-4657. (Pubitemid 30396112)
24. Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG. (1999). A new internal-ribosome-entry-site motif potentiates XIAP-mediated cyto-protection. Nat Cell Biol 1: 190-192. (Pubitemid 129656025)
25. Holcik M, Sonenberg N. (2005). Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318-327. (Pubitemid 40516898)
26. Holcik M, Sonenberg N, Korneluk RG. (2000a). Internal ribosome initiation of translation and the control of cell death. Trends in Genetics 16: 469-473.
27. Holcik M, Yeh C, Korneluk RG, Chow T. (2000b). Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19: 4174-4177.
28. Kullmann M, Gopfert U, Siewe B, Hengst L. (2002). ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev 16: 3087-3099. (Pubitemid 35424195)
29. Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M. (2005). Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. Embo J 24: 1852-1862. (Pubitemid 40769504)
30. Lewis SM, Veyrier A, Hosszu Ungureanu N, Bonnal S, Vagner S, Holcik M. (2007). Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. Mol Biol Cell 18: 1302-1311. (Pubitemid 46626625)
31. Liston P, Fong WG, Korneluk RG. (2003). The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568-8580. (Pubitemid 38019194)
32. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G et al. (1996). Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349-353. (Pubitemid 26033078)
33. MacGregor GR, Nolan GP, Fiering S, Roederer M, Herzenberg LA. (1991). Use of E. coli lacZ (b-Galactosidase) as a reporter gene. Methods in Molecular Biology, Vol. 7: Gene Transfer & Expression Protocols Murray Ej and Walker Jm (eds) Clifton,N.J, pp, Humana Press Inc., 217-235.
34. Mazroui R, Di Marco S, Clair E, von Roretz C, Tenenbaum SA, Keene JD et al. (2008). Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol 180: 113-127.
35. Meisner NC, Hackermuller J, Uhl V, Aszodi A, Jaritz M, Auer M. (2004). mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure. Chembiochem 5: 1432-1447. (Pubitemid 39371510)
36. Meng Z, King PH, Nabors LB, Jackson NL, Chen CY, Emanuel PD et al. (2005). The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation. Nucleic Acids Res 33: 2962-2979. (Pubitemid 41518704)
37. Myer VE, Fan XC, Steitz JA. (1997). Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. Embo J 16: 2130-2139. (Pubitemid 27170973)
38. Pardo OE, Lesay A, Arcaro A, Lopes R, Ng BL, Warne PH et al. (2003). Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol Cell Biol 23: 7600-7610. (Pubitemid 37271459)
39. Rivas-Aravena A, Ramdohr P, Vallejos M, Valiente-Echeverria F, Dormoy-Raclet V, Rodriguez F et al. (2009). The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites. Virology 392: 178-185.
40. Schimmer AD, Dalili S, Batey RA, Riedl SJ. (2005). Targeting XIAP for the treatment of malignancy. Cell Death Differ 2: 179-188. (Pubitemid 43102202)
41. Schimmer AD, Estey EH, Borthakur G, Carter BZ, Schiller GJ, Tallman MS et al. (2009). Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia. J Clin Oncol 27: 4741-4746.
42. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J et al. (2009). Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol 11: 903-908.
43. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S et al. (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803. (Pubitemid 30305074)
44. Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F et al. (2004a). High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res 10: 3737-3744. (Pubitemid 38697607)
45. Tamm I, Richter S, Scholz F, Schmelz K, Oltersdorf D, Karawajew L et al. (2004b). XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis. Hematol J 5: 489-495. (Pubitemid 40045282)
46. Wilkinson JC, Cepero E, Boise LH, Duckett CS. (2004). Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol 24: 7003-7014. (Pubitemid 39014428)
47. Yeh CH, Hung LY, Hsu C, Le SY, Lee PT, Liao WL et al. (2008). RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment. Mol Biol Cell 25: 25.
48. Yoo PS, Sullivan CA, Kiang S, Gao W, Uchio EM, Chung GG et al. (2009). Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival. Ann Surg Oncol 16: 200-207.
49. Yoon A, Peng G, Brandenburg Y, Zollo O, Xu W, Rego E et al. (2006). Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312: 902-906. (Pubitemid 43727321)
50. Zhang X, Zou T, Rao JN, Liu L, Xiao L, Wang PY et al. (2009). Stabilization of XIAP mRNA through the RNA binding protein HuR regulated by cellular polyamines. Nucleic Acids Res 37: 7623-7637.